Arch Aesthetic Plast Surg.  2013 Feb;19(1):7-12. 10.14730/aaps.2013.19.1.7.

Primary Breast Augmentation with Anatomical Form-stable Implant

Affiliations
  • 1Parkjinseok Aesthetic Clinic, Seoul, Korea. breastpark@naver.com

Abstract

The Natrelle(TM) 410 (Allergan Inc., Irvine, CA, USA) shaped, form-stable silicone gel implant was introduced in Europe in 1993. Its "form stability" relates to increased cohesiveness or stiffness of the gel filler, allowing the implant to maintain its shape in the upright position. The anatomical form-stable implant is helpful for reducing ripples and provides more natural looking due to less upper pole fullness, so it has some benefits for the thin patients. And it provides more expansion to the lower pole, it has also benefits for the ptotic breasts or constricted breasts. I have experienced 69 cases with anatomical form-stable implants (52 Polytech Replicon(R) (POLYTECH Health & Aesthetics, Dieburg, Germany) implants, 85 Natrelle(TM) 410 implants) from February to December of 2012. The most common used implants are MF295 g of Natrelle(TM) 410 and high profile 315 g of Polytech Replicon(R). I did reoperations for 2 breasts of 2 patients. One was due to hematoma and the other was due to displacement. Both cases are my early experiences of shaped implants. There is no other complication yet. I need longer follow-up period for the appropriate evaluation. In my early experiences, the results of anatomical form-stable implants seem to make less fullness of upper pole, less ripples, more tightness, and similar recovery periods in contrast with the results of round textured implants.

Keyword

Breast implants; Silicone gels; Anatomical models; Mammoplasty

MeSH Terms

Breast
Breast Implants
Displacement (Psychology)
Esthetics
Europe
Female
Follow-Up Studies
Hematoma
Humans
Mammaplasty
Models, Anatomic
Silicone Gels
Silicone Gels
Full Text Links
  • AAPS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr